ISSN: 1837-9664Journal of Cancer
Global reach, higher impact
J Cancer 2023; 14(2):318-321. doi:10.7150/jca.79828 This issue Cite
Erratum
miR-365a-3p regulates ADAM10-JAK-STAT signaling to suppress the growth and metastasis of colorectal cancer cells: Erratum
Yong-gang Hong1*, Cheng Xin1*, Ji-dian Zhou1, Xian-hua Gao1, Lun Hao2, Qi-zhi Liu1, Wei Zhang1 
, Li-qiang Hao1
1. Department of Colorectal Surgery, Changhai Hospital, Second Military Medical University Shanghai, P.R. China, 200433
2. Pella Christian High School, Iowa, United States of America.
*These authors contributed equally to this work
Citation:
Hong Yg, Xin C, Zhou Jd, Gao Xh, Hao L, Liu Qz, Zhang W, Hao Lq. miR-365a-3p regulates ADAM10-JAK-STAT signaling to suppress the growth and metastasis of colorectal cancer cells: Erratum. J Cancer 2023; 14(2):318-321. doi:10.7150/jca.79828. https://www.jcancer.org/v14p0318.htm
Other stylesCorrected-article in J Cancer, Volume 11, 3634
In the initially published version of our article, we recently realized that there are errors in several figures and Table 2 due to misplace of images and data. The corrections are provided below.
Figure 1
Corrected Figure 1B-F. (B-C) Relative miR-365a-3p levels in 134 pairs of primary CRC patient tumor and paracancerous tissue as accessed via qRT-PCR. (T, tumor; ANT, adjacent nontumor tissue). (D) A gradual reduction in levels of miR-365a-3p was evident with increasing TNM stage (I-III). (E and F) The association between levels of miR-365a-3p and recurrence-free survival (RFS, E) and overall survival (OS, F) in these 134 patients was measured via the Kaplan-Meier method. *p < 0.05; ***p < 0.001.
Figure 3
Corrected Figure 3A and C. (A) Transwell-based invasion and migration assays were used to assess the impact of miR-365-3p overexpression on HCT116 and SW620 cell migratory and invasive activity, with representative images shown. (C) Levels of E-cadherin, N-cadherin, and vimentin were measured via Western blotting in CRC cells overexpressing miR-365a-3p.
Figure 5
Corrected Figure 5C. (C) HCT116 cell migration was assessed via Transwell assay following the indicated treatment combinations.
Figure 6
Corrected Figure 6. miR-365-3p regulates JAK/STAT signaling to inhibit CRC progression. (A and B) Western blotting as used to assess p-STAT3, STAT3, p-JAK2, JAK2, and EMT marker levels in SW620 and HCT116 cells.
Table 2
Corrected Table 2. Univariate and multivariate analyses of clinicopathologic parameters associated with recurrence-free survival and overall survival
Finally, the author list in the paper should be updated as above in this erratum.
The correction does not change the overall conclusions of this paper. We apologize for the error and for any inconvenience that may cause to the readers and the editors of this journal.
Author contact
Corresponding authors: Li-qiang Hao:hao_liqiangcom; Wei Zhang: weizhang2000cncom
Published 2023-1-12
Citation styles
APA
Hong, Y.g., Xin, C., Zhou, J.d., Gao, X.h., Hao, L., Liu, Q.z., Zhang, W., Hao, L.q. (2023). miR-365a-3p regulates ADAM10-JAK-STAT signaling to suppress the growth and metastasis of colorectal cancer cells: Erratum. Journal of Cancer, 14(2), 318-321. https://doi.org/10.7150/jca.79828.
ACS
Hong, Y.g.; Xin, C.; Zhou, J.d.; Gao, X.h.; Hao, L.; Liu, Q.z.; Zhang, W.; Hao, L.q. miR-365a-3p regulates ADAM10-JAK-STAT signaling to suppress the growth and metastasis of colorectal cancer cells: Erratum. J. Cancer 2023, 14 (2), 318-321. DOI: 10.7150/jca.79828.
NLM
Hong Yg, Xin C, Zhou Jd, Gao Xh, Hao L, Liu Qz, Zhang W, Hao Lq. miR-365a-3p regulates ADAM10-JAK-STAT signaling to suppress the growth and metastasis of colorectal cancer cells: Erratum. J Cancer 2023; 14(2):318-321. doi:10.7150/jca.79828. https://www.jcancer.org/v14p0318.htm
CSE
Hong Yg, Xin C, Zhou Jd, Gao Xh, Hao L, Liu Qz, Zhang W, Hao Lq. 2023. miR-365a-3p regulates ADAM10-JAK-STAT signaling to suppress the growth and metastasis of colorectal cancer cells: Erratum. J Cancer. 14(2):318-321.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.